HTML Microdata document

This HTML5 document contains 56 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
dcterms	http://purl.org/dc/terms/
dbo	http://dbpedia.org/ontology/
foaf	http://xmlns.com/foaf/0.1/
n19	http://www.nasonline.org/about-nas/history/archives/collections/
dbpedia-es	http://es.dbpedia.org/resource/
n10	https://global.dbpedia.org/id/
dbt	http://dbpedia.org/resource/Template:
rdfs	http://www.w3.org/2000/01/rdf-schema#
freebase	http://rdf.freebase.com/ns/
n18	https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/enforcementactivitiesbyfda/selectedenforcementactionsonunapproveddrugs/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
owl	http://www.w3.org/2002/07/owl#
wikipedia-en	http://en.wikipedia.org/wiki/
dbc	http://dbpedia.org/resource/Category:
dbp	http://dbpedia.org/property/
prov	http://www.w3.org/ns/prov#
xsdh	http://www.w3.org/2001/XMLSchema#
gold	http://purl.org/linguistics/gold/
wikidata	http://www.wikidata.org/entity/
dbr	http://dbpedia.org/resource/

Statements

Subject Item: dbr:Regulation_of_therapeutic_goods
dbo:wikiPageWikiLink: dbr:Drug_Efficacy_Study_Implementation

Subject Item: dbr:Approved_Drug_Products_with_Therapeutic_Equivalence_Evaluations
dbo:wikiPageWikiLink: dbr:Drug_Efficacy_Study_Implementation

Subject Item: dbr:Stanozolol
dbo:wikiPageWikiLink: dbr:Drug_Efficacy_Study_Implementation

Subject Item: dbr:Desi_(disambiguation)
dbo:wikiPageWikiLink: dbr:Drug_Efficacy_Study_Implementation
dbo:wikiPageDisambiguates: dbr:Drug_Efficacy_Study_Implementation

Subject Item: dbr:Drug_Efficacy_Study_Implementation
rdf:type: dbo:Work
rdfs:label: Drug Efficacy Study Implementation Drug Efficacy Study Implementation
rdfs:comment: Drug Efficacy Study Implementation (DESI) was a program begun by the Food and Drug Administration (FDA) in the 1960s after the requirement (in the Kefauver-Harris Drug Control Act) that all drugs be efficacious as well as safe, was made part of US law. The DESI program was intended to classify all pre-1962 drugs that were already on the market as either effective, ineffective, or needing further study. The Drug Efficacy Study Implementation (DESI) evaluated over 3,000 separate products and over 16,000 therapeutic claims. By 1984, final action had been completed on 3,443 products; of these, 2,225 were found to be effective, 1,051 were found not effective, and 167 were pending. Drug Efficacy Study Implementation —DESI— (en español Implementación del Estudio de la Eficacia de los Medicamentos) fue un programa iniciado por la Food and Drug Administration (FDA) en la década de 1960 después que se requiriera (en la Ley de Control de Drogas Kefauver-Harris) que todos los medicamentos fueran eficaces y seguros. El programa DESI tenía la intención de clasificar a todos los medicamentos que ya estuvieran en el mercado previo a 1962, como eficaces, ineficaces, o con necesidad de más estudios. Se evaluaron más de 3 000 productos diferentes y más de 16 000 demandas terapéuticas. En 1984, se había completado todas las evaluaciones en 3 443 productos, de los cuales 2 225 resultaron ser efectivos, 1 051 ineficaces, y 167 en proceso de estudio. Uno de los primeros efectos de la
dcterms:subject: dbc:Pharmaceuticals_policy dbc:American_medical_research dbc:Food_and_Drug_Administration
dbo:wikiPageID: 2265601
dbo:wikiPageRevisionID: 930957979
dbo:wikiPageWikiLink: dbr:Estes_Kefauver dbr:Kefauver_Harris_Amendment dbc:Food_and_Drug_Administration dbr:Federal_Food,_Drug,_and_Cosmetic_Act dbc:American_medical_research dbc:Pharmaceuticals_policy dbr:Inverse_benefit_law dbr:Food_and_Drug_Administration dbr:Drug dbr:Abbreviated_New_Drug_Application dbr:Regulation_of_therapeutic_goods
dbo:wikiPageExternalLink: n18:ucm119899.pdf n19:des-1966-1969-1.html
owl:sameAs: freebase:m.06_bsk n10:4jBJS dbpedia-es:Drug_Efficacy_Study_Implementation wikidata:Q5308844
dbp:wikiPageUsesTemplate: dbt:HHS_content dbt:PMID dbt:US-gov-stub dbt:Reflist
dbo:abstract: Drug Efficacy Study Implementation —DESI— (en español Implementación del Estudio de la Eficacia de los Medicamentos) fue un programa iniciado por la Food and Drug Administration (FDA) en la década de 1960 después que se requiriera (en la Ley de Control de Drogas Kefauver-Harris) que todos los medicamentos fueran eficaces y seguros. El programa DESI tenía la intención de clasificar a todos los medicamentos que ya estuvieran en el mercado previo a 1962, como eficaces, ineficaces, o con necesidad de más estudios. Se evaluaron más de 3 000 productos diferentes y más de 16 000 demandas terapéuticas. En 1984, se había completado todas las evaluaciones en 3 443 productos, de los cuales 2 225 resultaron ser efectivos, 1 051 ineficaces, y 167 en proceso de estudio. Uno de los primeros efectos de la DESI el estudio fue el desarrollo de la —ANDA— (Solicitud de nuevo fármaco abreviada). Drug Efficacy Study Implementation (DESI) was a program begun by the Food and Drug Administration (FDA) in the 1960s after the requirement (in the Kefauver-Harris Drug Control Act) that all drugs be efficacious as well as safe, was made part of US law. The DESI program was intended to classify all pre-1962 drugs that were already on the market as either effective, ineffective, or needing further study. The Drug Efficacy Study Implementation (DESI) evaluated over 3,000 separate products and over 16,000 therapeutic claims. By 1984, final action had been completed on 3,443 products; of these, 2,225 were found to be effective, 1,051 were found not effective, and 167 were pending. One of the early effects of the DESI study was the development of the Abbreviated New Drug Application (ANDA).
gold:hypernym: dbr:Program
prov:wasDerivedFrom: wikipedia-en:Drug_Efficacy_Study_Implementation?oldid=930957979&ns=0
dbo:wikiPageLength: 1931
foaf:isPrimaryTopicOf: wikipedia-en:Drug_Efficacy_Study_Implementation

Subject Item: dbr:DESI
dbo:wikiPageWikiLink: dbr:Drug_Efficacy_Study_Implementation
dbo:wikiPageDisambiguates: dbr:Drug_Efficacy_Study_Implementation

Subject Item: dbr:Adderall
dbo:wikiPageWikiLink: dbr:Drug_Efficacy_Study_Implementation

Subject Item: dbr:Federal_Food,_Drug,_and_Cosmetic_Act
dbo:wikiPageWikiLink: dbr:Drug_Efficacy_Study_Implementation

Subject Item: dbr:Food_and_Drug_Administration
dbo:wikiPageWikiLink: dbr:Drug_Efficacy_Study_Implementation

Subject Item: dbr:Thalidomide
dbo:wikiPageWikiLink: dbr:Drug_Efficacy_Study_Implementation

Subject Item: dbr:Kefauver–Harris_Amendment
dbo:wikiPageWikiLink: dbr:Drug_Efficacy_Study_Implementation

Subject Item: dbr:Regulation_of_food_and_dietary_supplements_by_the_U.S._Food_and_Drug_Administration
dbo:wikiPageWikiLink: dbr:Drug_Efficacy_Study_Implementation

Subject Item: dbr:Thalidomide_scandal
dbo:wikiPageWikiLink: dbr:Drug_Efficacy_Study_Implementation

Subject Item: dbr:Piperidione
dbo:wikiPageWikiLink: dbr:Drug_Efficacy_Study_Implementation

Subject Item: dbr:Metandienone
dbo:wikiPageWikiLink: dbr:Drug_Efficacy_Study_Implementation

Subject Item: dbr:Obetrol
dbo:wikiPageWikiLink: dbr:Drug_Efficacy_Study_Implementation

Subject Item: dbr:Multivitamin
dbo:wikiPageWikiLink: dbr:Drug_Efficacy_Study_Implementation

Subject Item: wikipedia-en:Drug_Efficacy_Study_Implementation
foaf:primaryTopic: dbr:Drug_Efficacy_Study_Implementation